Impact of Polysaccharides from Traditional Chinese Medicine on Rheumatoid Arthritis via Gut Microbiota Alteration: A Systematic Review of Animal Studies - Top-Institutions - MDSpire

Impact of Polysaccharides from Traditional Chinese Medicine on Rheumatoid Arthritis via Gut Microbiota Alteration: A Systematic Review of Animal Studies

  • By

  • Suhai Qian

  • Yibo Jin

  • Chao Hu

  • Yuanyuan Luo

  • Runyu Chang

  • Jingyi Wu

  • Xinghong Ding

  • April 23, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Peking University Health Science Center
    Peking University Health Science Center

    Beijing, Beijing

    Key Differentiators

    • Rheumatology
    • Traditional Chinese Medicine
    • Microbiome Research

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, Maryland

    Key Differentiators

    • Rheumatology
    • Immunology
    • Microbiome Science

  • #3

    University of California, San Francisco (UCSF) School of Medicine
    University of California, San Francisco (UCSF) School of Medicine

    San Francisco, California

    Key Differentiators

    • Rheumatology
    • Microbiome Research
    • Translational Medicine

  • #4

    Shanghai Jiao Tong University School of Medicine
    Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai

    Key Differentiators

    • Traditional Chinese Medicine
    • Rheumatology
    • Microbiome

  • #5

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Rheumatology
    • Immunology
    • Microbiome Research

Original Source(s)

Impact of Polysaccharides from Traditional Chinese Medicine on Rheumatoid Arthritis via Gut Microbiota Alteration: A Systematic Review of Animal Studies

  • by Suhai Qian, Yibo Jin, Chao Hu, Yuanyuan Luo, Runyu Chang, Jingyi Wu, Xinghong Ding

  • April 23, 2026

Related Content

PR Flares Linked to Future Arthritis Sites

Persistent arthritis often develops in joints affected during earlier flares

FDA Clears Golimumab Biosimilars

New biosimilars enter the market with pharmacy-level substitution eligibility for rheumatology and gastroenterology indications.

Efficacy and safety of upadacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis